An analyst from Canaccord Genuity maintained Regulus Therapeutics (NASDAQ: RGLS) at 'buy' with a price target of $12.00 from a prior price target of $9.00. Prior to this rating, Regulus...
Regulus Therapeutics Inc (NASDAQ: RGLS) released topline results from the first cohort of patients in its Phase 1b Multiple-Ascending Dose (MAD) trial of RGLS8429 for Autosomal Dominant...
Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today...
Investing.com - Regulus Therapeutics (NASDAQ: RGLS) reported second quarter EPS of $-0.3700, $0.04 better than the analyst estimate of $-0.4100. Revenue for the quarter came in at $0.00...
Regulus (NASDAQ:RGLS) Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or...
Regulus (NASDAQ:RGLS) Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or...
Regulus Therapeutics (NASDAQ:RGLS) has filed for up to 16,698,236 share offering by selling stockholders.
Investing.com - Regulus Therapeutics (NASDAQ: RGLS) reported first quarter EPS of $-0.4200, $0.03 better than the analyst estimate of $-0.4500. Revenue for the quarter came in at $0.00...
A H.C. Wainwright analyst maintained Regulus Therapeutics (NASDAQ: RGLS) at Buy and a price target of $9.00 from a prior price target of $20.00. Prior to this rating, Regulus Therapeutics...
Regulus (NASDAQ:RGLS) Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or...
Regulus (NASDAQ:RGLS) Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or...
Investing.com - Regulus Therapeutics (NASDAQ: RGLS) reported fourth quarter EPS of $-0.4000, $0.10 better than the analyst estimate of $-0.5033. Revenue for the quarter came in at $0.00...
Investing.com - Regulus Therapeutics reported on Thursday third quarter {{erl-40092||earnings that missed analysts' forecasts and revenue that was inline with expectations. Regulus...
Regulus Therapeutics (RGLS) reported Q3 EPS of ($0.50), in-line with the analyst estimate of ($0.50).
Investing.com – U.S. equities were lower at the close on Wednesday, as losses in the Technology, Consumer Services and Consumer Goods sectors propelled shares lower. At the close in NYSE,...
Investing.com – U.S. equities were higher at the close on Wednesday, as gains in the Basic Materials, Financials and Oil & Gas sectors propelled shares higher. At the close in NYSE, the Dow...
Investing.com – U.S. equities were mixed at the close on Wednesday, as gains in the Utilities, Basic Materials and Technology sectors propelled shares higher while losses in the Financials,...
Investing.com – U.S. equities were mixed at the close on Monday, as gains in the Oil & Gas, Basic Materials and Healthcare sectors propelled shares higher while losses in the Technology,...
Investing.com – U.S. equities were higher at the close on Thursday, as gains in the Technology, Oil & Gas and Financials sectors propelled shares higher. At the close in NYSE, the Dow Jones...
Investing.com – U.S. equities were mixed at the close on Wednesday, as gains in the Telecoms, Technology and Financials sectors propelled shares higher while losses in the Consumer Goods,...
Investing.com – U.S. equities were higher at the close on Tuesday, as gains in the Technology, Basic Materials and Consumer Services sectors propelled shares higher. At the close in NYSE,...
Investing.com – U.S. equities were higher at the close on Tuesday, as gains in the Consumer Services, Technology and Financials sectors propelled shares higher. At the close in NYSE, the...
Investing.com – U.S. equities were higher at the close on Tuesday, as gains in the Consumer Services, Financials and Basic Materials sectors propelled shares higher. At the close in NYSE,...
Investing.com – U.S. equities were higher at the close on Friday, as gains in the Healthcare, Technology and Consumer Services sectors propelled shares higher. At the close in NYSE, the Dow...
Investing.com – U.S. equities were higher at the close on Thursday, as gains in the Consumer Goods, Healthcare and Utilities sectors propelled shares higher. At the close in NYSE, the Dow...
Investing.com – U.S. equities were lower at the close on Monday, as losses in the Oil & Gas, Basic Materials and Technology sectors propelled shares lower. At the close in NYSE, the Dow...
Investing.com – U.S. equities were higher at the close on Tuesday, as gains in the Oil & Gas, Financials and Healthcare sectors propelled shares higher. At the close in NYSE, the Dow Jones...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
